Treatment of Juvenile Onset Recurrent Respiratory Papillomatosis
Author Information
Author(s): Dyrstad Sara W., Rao Krishna A.
Primary Institution: Southern Illinois University School of Medicine
Hypothesis
Can chemotherapy and other treatments effectively manage juvenile onset recurrent respiratory papillomatosis (JORRP) that progresses to carcinoma?
Conclusion
The study found that while initial treatments reduced papilloma growth, the disease ultimately became resistant and progressed to invasive carcinoma.
Supporting Evidence
- The patient initially responded to chemotherapy but later developed resistance.
- Multiple treatment modalities were used, including surgery and chemotherapy.
- The disease progressed despite various interventions over a long period.
Takeaway
This study looks at a patient with a long history of a throat disease caused by a virus, which got worse over time despite various treatments. It shows that some treatments worked at first, but eventually, the disease became too strong for them.
Methodology
The case report details the treatment of a patient with JORRP using various therapies including chemotherapy, radiation, and surgery.
Limitations
The case report is based on a single patient, limiting the generalizability of the findings.
Participant Demographics
The patient was a 75-year-old female with a long history of JORRP.
Want to read the original?
Access the complete publication on the publisher's website